Bring the Future of Medicine to Your Practice
Modular integration. Exclusive technology. Strategic collaboration.
Biogenix is built for Medicine 3.0 - the global shift from reactive healthcare to precision, preventative, and performance-driven medicine. We partner with doctors, clinics, wellness centres, and health entrepreneurs to deliver the next generation of diagnostics, therapeutics, and regenerative protocols, backed by world-class technologies and clinical credibility.
Whether you’re evolving your current practice or launching a future-facing venture, Biogenix empowers you to lead in longevity, aesthetics, and regenerative medicine, with full medical, operational, and scientific support.
Why it matters
The future of medicine is not about treating disease, it’s about optimising human potential. Patients are demanding more: longer healthspans, peak performance, cognitive clarity, and visible anti-aging results.
The global medical wellness market is projected to surpass USD $2 trillion by 2030, driven by exponential growth in stem cell therapies, peptides, epigenetic diagnostics, biologics, and advanced IV-based therapeutics. Clinicians and operators who adopt these capabilities today are securing their position in tomorrow’s highest-growth medical sector.
Ways to implement Biogenix
The Biogenix advantage
Who it’s for
Let’s explore what’s possible
Distribute the Future of Regenerative Medicine and Biologics
World-class biologics. German-engineered tech. Exclusive territory partnerships.
Biogenix is the official and exclusive distributor for Cervos KeyPRP™, Marrow Cellution™ and Cryofos™ across Australia and select Asia-Pacific markets. These are not generic products - they are best-in-class systems, trusted by clinicians worldwide, backed by real-world data, and engineered for results.
We don’t just offer them, we use them ourselves. Why? Because Biogenix only delivers what meets the highest standards of safety, science, and clinical performance.
Cervos KeyPRP™
Revolutionise PRP. Zero Guesswork. Maximum Yield.
Cervos KeyPRP™ is a state-of-the-art, single-use PRP kit engineered to streamline and optimise platelet-rich plasma therapy. With its patented closed system, intuitive workflow, and high-yield platelet capture, it delivers reproducible results with no contamination risk - ideal for both aesthetic and orthopaedic applications.
TGA-approved and CE-certified, it’s trusted across leading clinics in Europe, the USA, and Canada, and now available exclusively in Australia via Biogenix.
Key features:
- Needleless injection ports - no contamination risk
- No ventilation ports - 100% closed system
- Intuitive protocol - no technical training required
- Process as little as 20–30 mL or up to 80 mL of blood
- No dedicated centrifuge platform required
- Customisable PRP outputs - monocyte- and lymphocyte-rich
- Platelet recovery up to 78%, lymphocytes 77%, with <5% granulocytes
- TGA-registered for use in medical and aesthetic practices
Indications include:
- Facial rejuvenation, skin tightening, décolletage, and periorbital revitalisation
- Hair loss and alopecia (androgenic or diffuse)
- Orthopaedic and sports-related injuries (tendons, ligaments, joints)
- Post-surgical wound healing and scar modulation
- Pain management and MSK recovery
- Adjuvant to biologic therapies (e.g., stem cells, exosomes)